Avricore Health (AVCRF) Investment Income (2024 - 2025)
Avricore Health (AVCRF) reported Investment Income of $172.94 for Q3 2025, up 571.83% year-over-year from $25.74 in Q3 2024, and up 135.03% quarter-over-quarter from -$493.65 in Q2 2025.
Avricore Health (AVCRF) Investment Income (2024 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 2 years of Investment Income data on file, last reported at $172.94 in Q3 2025.
- Investment Income for Q3 2025 came in at $172.94, up 571.83% year-over-year; the trailing twelve-month figure through Sep 2025 was -$314.16 (changed N/A YoY), and the FY2025 annual result was -$66.56, down 93.9% from the prior year.
- Investment Income rose to $172.94 in Q3 2025 per AVCRF's latest filing, from -$493.65 in the prior quarter.
- Over five years, Investment Income peaked at $172.94 in Q3 2025 and troughed at -$493.65 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | - |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | - |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 172.94 |
| Jun 30, 2025 | -493.65 |
| Mar 31, 2025 | 43.21 |
| Sep 30, 2024 | -36.65 |